Mitofusin 1 degradation is induced by a disruptor of mitochondrial calcium homeostasis, CGP37157: A role in apoptosis in prostate cancer cells

Choudhary,Vivek; Kaddour-Djebbar,Ismail; Alaisami,Rabei; Kumar,M.  Vijay; Bollag,Wendy B.

doi:10.3892/ijo.2014.2343

Mitofusin 1 degradation is induced by a disruptor of mitochondrial calcium homeostasis, CGP37157: A role in apoptosis in prostate cancer cells

Authors:
- Vivek Choudhary
- Ismail Kaddour-Djebbar
- Rabei Alaisami
- M. Vijay Kumar
- Wendy B. Bollag
View Affiliations

Affiliations: Charlie Norwood VA Medical Center, Augusta, GA, USA, Department of Physiology, Medical College of Georgia at Georgia Regents University, Augusta, GA, USA
Published online on: March 13, 2014 https://doi.org/10.3892/ijo.2014.2343
Pages: 1767-1773

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mitochondria constantly divide (mitochondrial fission) and fuse (mitochondrial fusion) in a normal cell. Disturbances in the balance between these two physiological processes may lead to cell dysfunction or to cell death. Induction of cell death is the prime goal of prostate cancer chemotherapy. Our previous study demonstrated that androgens increase the expression of a mitochondrial protein involved in fission and facilitate an apoptotic response to CGP37157 (CGP), an inhibitor of mitochondrial calcium efflux, in prostate cancer cells. However, the regulation and role of mitochondrial fusion proteins in the death of these cells have not been examined. Therefore, our objective was to investigate the effect of CGP on a key mitochondrial fusion protein, mitofusin 1 (Mfn1), and the role of Mfn1 in prostate cancer cell apoptosis. We used various prostate cancer cell lines and western blot analysis, qRT-PCR, siRNA, M30 apoptosis assay and immunoprecipitation techniques to determine mechanisms regulating Mfn1. Treatment of prostate cancer cells with CGP resulted in selective degradation of Mfn1. Mfn1 ubiquitination was detected following immunoprecipitation of overexpressed Myc-tagged Mfn1 protein from CGP-treated cells, and treatment with the proteasomal inhibitor lactacystin, as well as siRNA-mediated knockdown of the E3 ubiquitin ligase March5, protected Mfn1 from CGP-induced degradation. These data indicate the involvement of the ubiquitin-proteasome pathway in CGP-induced degradation of Mfn1. We also demonstrated that downregulation of Mfn1 by siRNA enhanced the apoptotic response of LNCaP cells to CGP, suggesting a likely pro-survival role for Mfn1 in these cells. Our results suggest that manipulation of mitofusins may provide a novel therapeutic advantage in treating prostate cancer.

View Figures

View References

1.	Chen G, Wang F, Trachootham D and Huang P: Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion. 10:614–625. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Frezza C, Pollard PJ and Gottlieb E: Inborn and acquired metabolic defects in cancer. J Mol Med (Berl). 89:213–220. 2011. View Article : Google Scholar : PubMed/NCBI
3.	Kuznetsov AV, Margreiter R, Amberger A, Saks V and Grimm M: Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta. 1813:1144–1152. 2011. View Article : Google Scholar
4.	Willers IM and Cuezva JM: Post-transcriptional regulation of the mitochondrial H(+)-ATP synthase: a key regulator of the metabolic phenotype in cancer. Biochim Biophys Acta. 1807:543–551. 2010.
5.	McBride HM, Neuspiel M and Wasiak S: Mitochondria: more than just a powerhouse. Curr Biol. 16:R551–R560. 2006. View Article : Google Scholar : PubMed/NCBI
6.	Bereiter-Hahn J and Voth M: Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech. 27:198–219. 1994. View Article : Google Scholar : PubMed/NCBI
7.	Griparic L and van der Bliek AM: The many shapes of mitochondrial membranes. Traffic. 2:235–244. 2001. View Article : Google Scholar : PubMed/NCBI
8.	Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwarzenbacher R and Lipton SA: Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol. 15:706–716. 2003. View Article : Google Scholar
9.	Skulachev VP: Mitochondrial filaments and clusters as intra-cellular power-transmitting cables. Trends Biochem Sci. 26:23–29. 2001. View Article : Google Scholar : PubMed/NCBI
10.	Brooks C, Wei Q, Cho SG and Dong Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 119:1275–1285. 2009. View Article : Google Scholar : PubMed/NCBI
11.	Choudhary V, Kaddour-Djebbar I, Lakshmikanthan V, et al: Novel role of androgens in mitochondrial fission and apoptosis. Mol Cancer Res. 9:1067–1077. 2011. View Article : Google Scholar : PubMed/NCBI
12.	Frank S, Gaume B, Bergmann-Leitner ES, et al: The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell. 1:515–525. 2001. View Article : Google Scholar : PubMed/NCBI
13.	Gomez-Lazaro M, Bonekamp NA, Galindo MF, Jordan J and Schrader M: 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic Biol Med. 44:1960–1969. 2008. View Article : Google Scholar
14.	Kaddour-Djebbar I, Choudhary V, Brooks C, et al: Specific mitochondrial calcium overload induces mitochondrial fission in prostate cancer cells. Int J Oncol. 36:1437–1444. 2010.PubMed/NCBI
15.	Gandre-Babbe S and van der Bliek AM: The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. Mol Biol Cell. 19:2402–2412. 2008. View Article : Google Scholar : PubMed/NCBI
16.	Loson OC, Song Z, Chen H and Chan DC: Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 24:659–667. 2013. View Article : Google Scholar : PubMed/NCBI
17.	Otera H, Wang C, Cleland MM, et al: Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol. 191:1141–1158. 2010. View Article : Google Scholar : PubMed/NCBI
18.	Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE and Ryan MT: MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep. 12:565–573. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Zhao J, Liu T, Jin S, et al: Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J. 30:2762–2778. 2011. View Article : Google Scholar
20.	Cipolat S, Martins de Brito O, Dal Zilio B and Scorrano L: OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA. 101:15927–15932. 2004. View Article : Google Scholar : PubMed/NCBI
21.	Song Z, Ghochani M, McCaffery JM, Frey TG and Chan DC: Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell. 20:3525–3532. 2009. View Article : Google Scholar : PubMed/NCBI
22.	Ishihara N, Eura Y and Mihara K: Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 117:6535–6546. 2004. View Article : Google Scholar : PubMed/NCBI
23.	Rojo M, Legros F, Chateau D and Lombes A: Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci. 115:1663–1674. 2002.PubMed/NCBI
24.	Santel A, Frank S, Gaume B, Herrler M, Youle RJ and Fuller MT: Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci. 116:2763–2774. 2003. View Article : Google Scholar : PubMed/NCBI
25.	Santel A and Fuller MT: Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 114:867–874. 2001.PubMed/NCBI
26.	Eura Y, Ishihara N, Yokota S and Mihara K: Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J Biochem. 134:333–344. 2003. View Article : Google Scholar : PubMed/NCBI
27.	Honda S, Aihara T, Hontani M, Okubo K and Hirose S: Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J Cell Sci. 118:3153–3161. 2005. View Article : Google Scholar : PubMed/NCBI
28.	Yuan H, Gerencser AA, Liot G, et al: Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons. Cell Death Differ. 14:462–471. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Barsoum MJ, Yuan H, Gerencser AA, et al: Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25:3900–3911. 2006. View Article : Google Scholar : PubMed/NCBI
30.	Cohen MM, Amiott EA, Day AR, et al: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCF Mdm30 in mitochondrial outer membrane fusion. J Cell Sci. 124:1403–1410. 2011. View Article : Google Scholar : PubMed/NCBI
31.	Cohen MM, Leboucher GP, Livnat-Levanon N, Glickman MH and Weissman AM: Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion. Mol Biol Cell. 19:2457–2464. 2008. View Article : Google Scholar : PubMed/NCBI
32.	Park YY, Lee S, Karbowski M, Neutzner A, Youle RJ and Cho H: Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J Cell Sci. 123:619–626. 2010. View Article : Google Scholar : PubMed/NCBI
33.	Kaddour-Djebbar I, Lakshmikanthan V, Shirley RB, Ma Y, Lewis RW and Kumar MV: Therapeutic advantage of combining calcium channel blockers and TRAIL in prostate cancer. Mol Cancer Ther. 5:1958–1966. 2006. View Article : Google Scholar : PubMed/NCBI
34.	Jiang S, Zu Y, Wang Z, Zhang Y and Fu Y: Involvement of mitochondrial permeability transition pore opening in 7-xylosyl-10-deacetylpaclitaxel-induced apoptosis. Planta Med. 77:1005–1012. 2011. View Article : Google Scholar : PubMed/NCBI
35.	Karbowski M and Youle RJ: Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ. 10:870–880. 2003. View Article : Google Scholar : PubMed/NCBI
36.	Yingkun N, Lvsong Z and Huimin Y: Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells. Can J Physiol Pharmacol. 88:1138–1146. 2010. View Article : Google Scholar : PubMed/NCBI
37.	Knott AB and Bossy-Wetzel E: Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann NY Acad Sci. 1147:283–292. 2008. View Article : Google Scholar : PubMed/NCBI
38.	Wasilewski M and Scorrano L: The changing shape of mitochondrial apoptosis. Trends Endocrinol Metab. 20:287–294. 2009. View Article : Google Scholar
39.	Chang CR and Blackstone C: Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem. 282:21583–21587. 2007. View Article : Google Scholar : PubMed/NCBI
40.	Cribbs JT and Strack S: Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8:939–944. 2007. View Article : Google Scholar
41.	Taguchi N, Ishihara N, Jofuku A, Oka T and Mihara K: Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem. 282:11521–11529. 2007. View Article : Google Scholar : PubMed/NCBI
42.	Escobar-Henriques M, Westermann B and Langer T: Regulation of mitochondrial fusion by the F-box protein Mdm30 involves proteasome-independent turnover of Fzo1. J Cell Biol. 173:645–650. 2006. View Article : Google Scholar : PubMed/NCBI
43.	Chan NC, Salazar AM, Pham AH, et al: Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet. 20:1726–1737. 2011. View Article : Google Scholar : PubMed/NCBI
44.	Rakovic A, Grunewald A, Kottwitz J, et al: Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. PLoS One. 6:e167462011. View Article : Google Scholar : PubMed/NCBI
45.	Nakamura N, Kimura Y, Tokuda M, Honda S and Hirose S: MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 7:1019–1022. 2006. View Article : Google Scholar : PubMed/NCBI
46.	Chiche J, Rouleau M, Gounon P, Brahimi-Horn MC, Pouyssegur J and Mazure NM: Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol. 222:648–657. 2010.PubMed/NCBI
47.	Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM and Hausenloy DJ: Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 121:2012–2022. 2010. View Article : Google Scholar : PubMed/NCBI